Jonathan Russell
Ophthalmology · Iowa City, IANPI 1013301910
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (49.0%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Carl Zeiss Meditec, Inc. accounts for 61.3% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2019 at $1,165 and has fallen 97.0% since, to $35 in 2025.
Across 20 payments — averaging $203.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Carl Zeiss Meditec, Inc.$3K
- Alcon$1K
- Spark Therapeutics, Inc.$120
- Novartis$117
- Johnson & Johnson Surgical Vision, Inc.$41
- Genentech USA, Inc.$35
- plus $40 from 2 others
What the payments were for
- Consulting fees$50012%
- Speaking & faculty fees$2,00049%
- Travel & lodging$74318%
- Food & beverage$83520%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Carl Zeiss Meditec, Inc. | 3 | $2,500 |
| Alcon | 7 | $1,225 |
| Spark Therapeutics, Inc. | 4 | $120 |
| Novartis | 1 | $117 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $41 |
| Genentech USA, Inc. | 2 | $35 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $22 |
| Bausch & Lomb Americas Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CIRRUS 5000$1,000
- FORUM$1,000
- PRESBYOND$500
- RESCAN 700$500
- VERACITY SURGICAL$500
- VisuMax$500
- QUATERA 700$500
- DAILIES$423
- DUREZOL$117
- AcrySof IQ VIVITY IOL$112
How this compares
$4,078 in reported general payments places this provider in the 75th percentile of 172 ophthalmology providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 71 | $3,137 |
| Ketorolac Tromethamine | 41 | $847 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 41 | $487 |
| Latanoprost | 45 | $335 |
| Dorzolamide Hcl | 13 | $217 |
| Brimonidine Tartrate | 18 | $122 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Iowa City
- Michael AbramoffIowa City$158K
- Stephen RussellIowa City$137K
- Alina DumitrescuIowa City$57K
- Keith CarterIowa City$54K
- Erin ShriverIowa City$43K
- James FolkIowa City$34K
- Marc Toeteberg-HarmsIowa City$21K
- Randy KardonIowa City$15K
- Elliott SohnIowa City$7K
- Sohan HayrehIowa City$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.